A detailed history of Trexquant Investment LP transactions in Neogenomics Inc stock. As of the latest transaction made, Trexquant Investment LP holds 203,669 shares of NEO stock, worth $3.09 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
203,669
Previous 42,545 378.71%
Holding current value
$3.09 Million
Previous $590,000 409.15%
% of portfolio
0.04%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$13.4 - $17.73 $2.16 Million - $2.86 Million
161,124 Added 378.71%
203,669 $3 Million
Q2 2024

Aug 13, 2024

SELL
$13.01 - $15.77 $666,268 - $807,613
-51,212 Reduced 54.62%
42,545 $590,000
Q1 2024

May 14, 2024

BUY
$14.06 - $16.79 $1.32 Million - $1.57 Million
93,757 New
93,757 $1.47 Million
Q3 2023

Nov 13, 2023

SELL
$12.15 - $17.85 $323,846 - $475,773
-26,654 Reduced 22.36%
92,573 $1.14 Million
Q2 2023

Aug 11, 2023

SELL
$14.1 - $19.83 $1.07 Million - $1.51 Million
-76,028 Reduced 38.94%
119,227 $1.92 Million
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $1.3 Million - $2.77 Million
142,488 Added 270.03%
195,255 $3.4 Million
Q4 2022

Feb 13, 2023

BUY
$6.45 - $12.07 $153,368 - $287,000
23,778 Added 82.02%
52,767 $487,000
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $227,853 - $374,247
28,989 New
28,989 $250,000
Q1 2022

May 13, 2022

SELL
$12.15 - $35.28 $219,805 - $638,250
-18,091 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $551,594 - $877,232
18,091 New
18,091 $617,000
Q2 2021

Aug 12, 2021

SELL
$36.62 - $51.69 $673,991 - $951,354
-18,405 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$41.56 - $59.88 $521,536 - $751,434
12,549 Added 214.29%
18,405 $888,000
Q4 2020

Feb 11, 2021

SELL
$36.08 - $56.47 $381,654 - $597,339
-10,578 Reduced 64.37%
5,856 $315,000
Q3 2020

Nov 06, 2020

BUY
$33.26 - $40.48 $546,594 - $665,248
16,434 New
16,434 $606,000
Q4 2019

Feb 12, 2020

SELL
$18.96 - $29.84 $319,950 - $503,550
-16,875 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$19.12 - $26.24 $322,650 - $442,800
16,875 New
16,875 $323,000
Q2 2019

Aug 09, 2019

SELL
$19.57 - $24.1 $944,213 - $1.16 Million
-48,248 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$12.14 - $20.46 $337,637 - $569,033
-27,812 Reduced 36.57%
48,248 $987,000
Q4 2018

Feb 13, 2019

BUY
$11.24 - $18.5 $854,914 - $1.41 Million
76,060 New
76,060 $959,000
Q2 2018

Aug 07, 2018

SELL
$7.99 - $14.05 $353,964 - $622,429
-44,301 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$7.23 - $8.76 $320,296 - $388,076
44,301 New
44,301 $361,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.91B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.